Evaluation of MHC class I-binding peptides from Leishmania spp. for vaccine development against visceral leishmaniasis. Zaidan AL, Grossi de Oliveira AL, Brito RMM, Bueno LL, et al. Vaccine 2025;62:127531.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zaidan AL, Grossi de Oliveira AL, Brito RMM, Bueno LL, et al. Evaluation of MHC class I-binding peptides from Leishmania spp. for vaccine development against visceral leishmaniasis. Vaccine 2025;62:127531.
PMID: 40706507